These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 787954)

  • 21. High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences.
    Zito RA; Cassell I; Cunningham M; Gradman AH; Ross AM; Zaret BL
    Yale J Biol Med; 1980; 53(3):173-9. PubMed ID: 6250292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF
    Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
    Frick MH; Luurila O
    Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The comparative efficacy of individually adjusted doses of proxodolol and propranolol for one-time and regular administration in stenocardia patients].
    Bochkareva EV; Kokurina EV; Metelitsa VI; Pankina VA
    Eksp Klin Farmakol; 1994; 57(3):51-4. PubMed ID: 7914122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Problems in selecting the optimal propranolol dose in treating patients with angina pectoris of effort and the comparative effectiveness of inderal, anaprilin and obzidan].
    Romakov AIu; Mazur NA
    Ter Arkh; 1984; 56(9):41-6. PubMed ID: 6515546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug therapy combinations in angina pectoris].
    Carù B; De Ponti C; De Biase AM
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():103-9. PubMed ID: 6407433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The properties of beta-adrenoceptor antagonists.
    Shanks RG
    Postgrad Med J; 1976; 52 Suppl 4():14-20. PubMed ID: 9628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
    Goldman S; Olajos M; Pieniaszek H; Perrier D; Mayersohn M; Morkin E
    J Pharmacol Exp Ther; 1981 Nov; 219(2):394-9. PubMed ID: 7288628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sotalol in angina pectoris. A double-blind study.
    Slome R
    S Afr Med J; 1976 Mar; 50(12):469-72. PubMed ID: 818720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
    Sandler G; Clayton GA
    Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
    [No Abstract]   [Full Text] [Related]  

  • 38. Protection from morbidity and mortality from first infarcts: the case for beta-blockade.
    Lambert DM
    Aust Fam Physician; 1978 Jun; Suppl():5-10. PubMed ID: 708313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
    Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
    Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.